共 102 条
[1]
Hebert LE(2013)Alzheimer disease in the United States (2010-2050) estimated using the 2010 census Neurology 80 1778-1783
[2]
Weuve J(2011)The costs of Alzheimer’s disease and the value of effective therapies Am J Manag Care 17 S356-S362
[3]
Scherr PA(1997)Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam study Lancet 349 151-154
[4]
Evans DA(2020)Low-density lipoprotein cholesterol and Alzheimer’s disease: a systematic review and meta-analysis Front Aging Neurosci 12 5-695
[5]
Stefanacci RG(2020)Plasma lipids as biomarkers for Alzheimer’s disease: a systematic review Cureus 12 e12008-251
[6]
Hofman A(2020)Cholesterol and Alzheimer’s disease risk: a meta-meta-analysis Brain Sci 10 386-215
[7]
Ott A(2019)Comparison of Medication Therapy Management services and their effects on health care utilization and medication adherence J Manag Care Spec Pharm 25 688-55
[8]
Breteler MM(2017)The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study Pharm Pract (Granada) 15 1026-1069
[9]
Bots ML(2019)Evolution of the Medicare Part D Medication Therapy Management program from inception in 2006 to the present Am Health Drug Benefits 12 243-154
[10]
Slooter AJ(2016)Disparity implications of proposed 2015 Medicare eligibility criteria for medication therapy management services J Pharm Health Serv Res 7 209-1302